These findings underscore the importance of antioxidant defences in preventing age‐related muscle degeneration and highlight the potential of augmenting PRDX3 and PRDX5 activity as a therapeutic strategy to combat sarcopenia and muscle aging. This evidence concerns the gene PRDX5 and sarcopenia.